Based on the large GWAS conducted across multiple autoimmune disease cohorts and recent findings from functional experiments, our understanding of the role of WDFY4 in the anti-viral and anti-tumour immune responses has markedly advanced in the past five years. The gene discussed is WDFY4; the disease is neoplasm.